Pharmaceutical and Medical Supply Procurement for Ministry of Defence

This tender presents a significant opportunity for the supply of a comprehensive range of pharmaceutical products to the Ministry of Defence, specifically through the Department of Defence Production, with Hindustan Aeronautics Limited (HAL) acting as the procuring organization. The bid, identified by GEM/2026/B/7867484, is open for submission from 31-10-2026 at 10:00 AM until 02-11-2026 at 10:00 AM. The overall requirement encompasses a substantial total quantity of 142,700 units, covering a diverse list of critical medications and medical supplies. These include various pediatric and adult formulations such as SYP CEFIXIME 50mg per 5ML, SYP AMBROXOL HCL and LEVOSALBUTAMOL and GUAIPHENESIN, and SYP MULTIVITAMIN MULTIMINERALS WITH LYSINE. Furthermore, the tender specifies a range of tablets and capsules addressing prevalent health conditions, including TAB GLIMEPRIDE 1mg and METFORMIN 1000 mg, TAB GLIMEPRIDE 2mg and METFORMIN 1000 mg, TAB SITAGLIPTIN 50MG and METFORMIN 500 mg, TAB METHILCOBALAMIN, CAP VITAMIN E 400mg, CAP LUTIN, TAB VITAMIN E ACETATE and LEVOCARNITINE TABLET, SYP RABEPRAZOLE 20MG, TAB RABEPRAZOLE 20MG and DOMPERIDONE 30MG CAP, CAP ESOMEPRAZOLE 40 TAB, CAP ESOMEPRAZOLE 40MG and DOMPERIDONE 30MG, FEXOFENADINE SYP, and ESOMEPRAZOLE 40 and LEVOSULPRIDE 75MG CAP. The inclusion of DISPOSABLE SYRINGE 2ml indicates a need for accompanying medical accessories. This procurement is crucial for the healthcare provisions of the Ministry of Defence, demanding reliable suppliers with the capacity to meet a broad spectrum of pharmaceutical needs.